Skip to content

Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order

Effects of an Ultra-brief Online Mindfulness-based Intervention on Mental Health During the Coronavirus Disease (COVID-19) Outbreak in Malaysia: A Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04536441
Enrollment
161
Registered
2020-09-02
Start date
2020-04-01
Completion date
2020-06-30
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Wellness, Psychological Distress, Psychological Security

Keywords

Mindfulness, Online Intervention, COVID-19, Movement Control Order

Brief summary

The federal government of Malaysia implemented a nationwide Movement Control Order (MCO) to control the COVID-19 outbreak. The MCO, however, has been found to have a negative impact on people's mental wellbeing. Interventions that can improve mental health under restricted movement condition is urgently. The present study investigated the impact of a brief, online mindfulness-based intervention on mental health using two-arm randomized controlled trial design. A total of 161 participants self-reported their feeling, anxiety, psychological insecurity, and well-being at baseline (T1) and post-test (T2), while 61 of them answered the same set of measures and the fear of COVID-19 scale in a follow-up study two weeks later (T3).

Interventions

BEHAVIORALUltra Brief Online Mindfulness-based Intervention

We adapted and contextualized the original RAIN protocol to local pandemic-induced lockdown situation, with short journaling prompts that engage participants in self-reflection. Journaling is known to be a creative way to engage people in a therapeutic activity which promotes self-awareness (Utley & Garza, 2011). Creating a visual narration of thoughts, feelings and experiences help individuals make internal experiences more tangible and manageable, especially during these uncertain times.

BEHAVIORALControl

The control group participants were asked to report preventive measures that they have taken to prevent COVID-19, ways that they obtained Movement Control Order news, and things that they wished to do once the Movement Control Order is lifted.

Sponsors

Sunway University
CollaboratorOTHER
Universiti Tunku Abdul Rahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* People residing in Malaysia during the Movement Control Order.

Exclusion criteria

* People who are unable to read or write in either Malay, English or Mandarin languages.

Design outcomes

Primary

MeasureTime frameDescription
Changes of Subjective Unit of DistressIt was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.This is being measured with the Subject Unit of Distress Scale.
Changes of Anxiety ScoresIt was being It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.This is being measured with the GAD-7 questionnaire.
Changes of Psychological InsecurityIt was being It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.This is being measured with the Psychological Insecurity Scale.

Secondary

MeasureTime frameDescription
Changes of General Well-beingIt was being It was measured at pre-intervention, post-intervention (through intervention completion, on average 10 minutes), and 2-week follow up.This is being measured with the WHO-5 Well-being Index questionnaire.
Fear of COVID-19It was being measured at 2-week follow up.This is being measured with the Fear of COVID-19 Scale.

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026